DeepSeq.AI Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

DeepSeq.AI General Information

Description

Developer of a protein engineering platform designed to transform the proteomics process with a screening strategy. The company's platform utilizes artificial intelligence and machine learning to cluster and search similar proteins based on their physical properties, predict potential interactions, and create synthetic sequences, enabling researchers to develop drugs in smart and efficient ways.

Contact Information

Website
www.deepseq.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3400 Cottage Way
  • Suite G2, Number 19243
  • Sacramento, CA 95825
  • United States
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 3400 Cottage Way
  • Suite G2, Number 19243
  • Sacramento, CA 95825
  • United States

DeepSeq.AI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DeepSeq.AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 31-Mar-2026 Completed Generating Revenue
4. Grant 19-Aug-2024 Completed Generating Revenue
3. Accelerator/Incubator 10-Apr-2024 Completed Generating Revenue
2. Accelerator/Incubator 30-Nov-2023 $190K Completed Generating Revenue
1. Seed Round 06-Nov-2023 $190K $190K Completed Generating Revenue
To view DeepSeq.AI’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DeepSeq.AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DeepSeq.AI Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Addin Ventures Venture Capital Minority
Illumina Ventures Venture Capital Minority
Ninety Nine Ventures Venture Capital Minority
NTU Ventures Venture Capital Minority
ZAKA VC Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

DeepSeq.AI FAQs

  • When was DeepSeq.AI founded?

    DeepSeq.AI was founded in 2019.

  • Where is DeepSeq.AI headquartered?

    DeepSeq.AI is headquartered in Sacramento, CA.

  • What is the size of DeepSeq.AI?

    DeepSeq.AI has 3 total employees.

  • What industry is DeepSeq.AI in?

    DeepSeq.AI’s primary industry is Discovery Tools (Healthcare).

  • Is DeepSeq.AI a private or public company?

    DeepSeq.AI is a Private company.

  • What is DeepSeq.AI’s current revenue?

    The current revenue for DeepSeq.AI is .

  • How much funding has DeepSeq.AI raised over time?

    DeepSeq.AI has raised $390K.

  • Who are DeepSeq.AI’s investors?

    Addin Ventures, Illumina Ventures, Ninety Nine Ventures, NTU Ventures, and ZAKA VC are 5 of 9 investors who have invested in DeepSeq.AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process